SCHEMBL6002883

SCHEMBL6002883

[O]C(=O)N(Cl)c1ccccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
ALDH1A1 P00352 3/20 0.40
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
POLB P06746 2/20 0.38
TSHR P16473 2/20 0.38
LMNA P02545 1/20 0.38
GPBAR1 Q8TDU6 1/20 0.35
KMT2A Q03164 2/20 0.34
ESR1 P03372 1/20 0.34
BCL2A1 Q16548 1/20 0.34
MEN1 O00255 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28587764 0.83 ALDH1A1 (0.41) CES2CES1ALDH1A1NPC1RAB9A
SCHEMBL665305 0.83 ALDH1A1 (0.45) CES2CES1ALDH1A1POLBTSHR
SCHEMBL29524083 0.81 GAA (0.41) CES2CES1ALDH1A1POLBTSHR
SCHEMBL3157322 0.81 GAA (0.41) CES2CES1ALDH1A1POLBTSHR
SCHEMBL4199099 0.81 CES2 (0.40) CES2CES1ALDH1A1NPC1RAB9A
Bicarbonate SCHEMBL29118429 0.80 ALDH1A1 (0.46) CES2CES1ALDH1A1POLBTSHR
SCHEMBL465872 0.78 POLB (0.40) CES2CES1ALDH1A1NPC1RAB9A
SCHEMBL2097563 0.77 GPBAR1 (0.47) CES2CES1ALDH1A1POLBTSHR
SCHEMBL28749055 0.76 MEN1 (0.41) CES2CES1ALDH1A1NPC1RAB9A
SCHEMBL11502164 0.76 BCL2A1 (0.40) CES2CES1ALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed
EP-1329160-A2 4-ACYLAMINOPYRAZOLE DERIVATIVES Sankyo Company, Limited (JP) 2003-07-23 EP disclosed